Irinotecan liposome is approved by the USFDA for first-line treatment of metastatic pancreatic adenocarcinoma
The Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin on February 13, 2024, for treating metastatic pancreatic adenocarcinoma as the..
Juvenile obesity is associated with increased risk of pancreatic cancer
Adolescent obesity is associated with many health problems in later life, and a large Israeli study has shown that the increased risk of fatal pancreatic cancer is one of them. For more than 20 years, researchers have tracked..
A breast cancer drug may be used to treat pancreatic cancer
The survival rate of pancreatic cancer is very low. In the past 40 years, the survival rate has not changed significantly. Finding effective treatments is an urgent challenge for researchers. For many years, tamoxifen has been us..
Scientists reveal the best way to treat pancreatic cancer
Specific molecular signals released by pancreatic cancer cells have been determined. Pancreatic cancer is usually detected after the disease has spread, and chemotherapy often has no effect on slowing the development of cancer. ..
New adjuvant therapy for pancreatic cancer comes out
In a recent interview, Dr. Afsaneh Barzi, assistant professor of clinical medicine at the University of Southern California Norris Comprehensive Cancer Center, told you about existing and emerging new adjuvant therapies for patien..
The discovery of new protein helps the treatment and prevention of pancreatic cancer
New research has found that pancreatic cancer cells rely heavily on a protein to grow and spread. The research results can bring new treatment and prevention strategies for pancreatic cancer.The American Cancer Society estimates ..
Gene mutation can increase women's risk of pancreatic cancer
A recent study published in the journal Cellular and Molecular Gastroenterology and Hepatology showed that a gene mutation called ATRX may lead to an increased risk of pancreatitis and pancreatic cancer in women. This study marks ..
Nobel Prize winner died of pancreatic cancer
Dr. Thomas A. Steitz died on October 9, 2018 at the age of 78, and died of pancreatic cancer. Steitz is the co-winner of the 2009 Nobel Prize in Chemistry.Steitz's research on the ribosome has had a profound impact, making the at..
New drugs for the treatment of pancreatic cancer
Ruiwen Zhang and Robert L. Boblitt from the University of Houston have developed a new pancreatic cancer drug. The research was published in the Journal of Cancer Research. The drug targets two genes at the same time, and this b..
Folic acid and vitamin B6 may prevent pancreatic cancer
A recent study published in the European Journal of Clinical Nutrition showed that diet may play a key role in preventing pancreatic cancer. The study investigated the link between pancreatic cancer risk and the intake of certain..